|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 401/12 | (2006.01) |
| A61K 31/4439 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 37/00 | (2006.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 27/00 | (2006.01) |
| (11) | Number of the document | 3448846 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17718558.4 |
| Date of filing the European patent application | 2017-04-25 | |
| (97) | Date of publication of the European application | 2019-03-06 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-26 |
| (46) | Date of publication of the claims translation | 2021-07-26 |
| (86) | Number | PCT/EP2017/059744 |
| Date | 2017-04-25 |
| (87) | Number | WO 2017/186689 |
| Date | 2017-11-02 |
| (30) | Number | Date | Country code |
| 16167652 | 2016-04-29 | EP |
| (72) |
THALER, Tobias, DE
PLATZEK, Johannes, DE
GUIMOND, Nicolas, DE
|
| (73) |
Bayer Pharma Aktiengesellschaft,
Müllerstrasse 178, 13353 Berlin,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Indazolų sintezė |
| SYNTHESIS OF INDAZOLES |
| Payment date | Validity (years) | Amount | |
| 2024-04-08 | 8 | 185.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2025-04-25 |